Summaries for patients. Response to cholesterol-lowering drugs in patients with and without HIV infection.
D019380:Anti-HIV Agents / Q000009:adverse effects*; D008078:Cholesterol, LDL / Q000097:blood; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D015248:Gemfibrozil / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D012189:Retrospective Studies; D014280:Triglycerides / Q000097:blood
D019380:Anti-HIV Agents; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D014280:Triglycerides; D015248:Gemfibrozil